Free Topic-Wise General Studies MCQs
Deepen your knowledge of gene editing with 30 advanced MCQs on CRISPR Cas9 structural components and clinical applications. This quiz covers the distinction between somatic and germline editing, the role of tracrRNA, and the precision of base and prime editing. Explore the impact of CRISPR on cancer immunotherapy, xenotransplantation, and sustainable agriculture through climate-smart crops.
Your Total Marks
Syncing Benchmark...
Want to redo this specific test later?
REF ID (Save this!):
Explanation: Because gene drives spread traits through entire wild populations, they pose the risk of permanent, irreversible ecological impacts if the modification behaves differently than predicted.
Explanation: In Type II systems (like Cas9), the host enzyme RNase III cleaves the double-stranded RNA formed by the tracrRNA and pre-crRNA to create mature guides.
Explanation: NTLA-2001 used lipid nanoparticles to deliver CRISPR components to the liver to knock down the TTR gene, marking a milestone for in vivo gene editing.
Explanation: Cas12a (Cpf1) belongs to the Type V class, utilizing a single RuvC domain and recognizing T-rich PAM sequences, unlike the G-rich PAM used by Cas9.
Explanation: In a gene drive, the 'cargo' is the specific genetic modification (e.g., malaria resistance) that is linked to the CRISPR machinery to be spread through a population.
Explanation: Prime editing uses a reverse transcriptase fused to a Cas9 nickase to write new genetic information directly from a pegRNA template into the DNA.
Explanation: Cas14 is exceptionally small (about 400-700 amino acids), roughly half the size of Cas9, making it highly attractive for compact gene-delivery systems.
Explanation: The pegRNA includes a Primer Binding Site (PBS) and a reverse transcriptase template at its 3' end, which are essential for synthesizing the new DNA sequence.
Explanation: dCas9 binds to the promoter or coding region and acts as a physical roadblock, preventing RNA polymerase from initiating or continuing transcription.
Explanation: Prime editing uses a 'nickase' Cas9 fused to a reverse transcriptase. It uses a prime editing guide RNA (pegRNA) to both find the target and write new DNA directly into the genome.
Explanation: A daisy-chain drive is a self-limiting gene drive that eventually 'runs out of steam' because its components are linked in a chain that gets diluted over generations, preventing it from spreading globally.
Explanation: Casgevy (exa-cel) is the first approved therapy using CRISPR-Cas9. It edits a patientβs own bone marrow stem cells to produce fetal hemoglobin, compensating for defective adult hemoglobin.
Explanation: Inactivating one of the two nuclease domains (HNH or RuvC) converts Cas9 into a nickase, which cuts only one strand of the DNA double helix instead of two.
Explanation: For laboratory use, scientists typically combine the target-specific crRNA and the scaffold tracrRNA into a single molecule called the single-guide RNA (sgRNA).
Explanation: Cas9 produces blunt ends by cutting both strands at the same position, whereas Cas12a produces staggered (sticky) ends with a 4-5 nucleotide overhang.
Explanation: HDR requires a sister chromatid as a template, which is only present when a cell is preparing to divide. This makes precise gene correction in non-dividing (post-mitotic) cells very challenging.
Explanation: The PAM-Interacting (PI) domain at the C-terminus of Cas9 is responsible for identifying and binding the Protospacer Adjacent Motif, initiating DNA unwinding.
Explanation: Cas1 and Cas2 are the most conserved CRISPR proteins; they function as an integrase complex to capture and insert new viral DNA spacers into the genome.
Explanation: The Cas9 protein is a nuclease, an enzyme capable of creating double-strand breaks in the DNA backbone at a location specified by the guide RNA.
Explanation: The precision of RNA-guided targeting allows CRISPR-based tools to detect even single-nucleotide differences in viral or bacterial DNA/RNA, making them powerful for rapid diagnostics.
Explanation: Acquisition is the first stage where the Cas1-Cas2 complex identifies foreign DNA and integrates a segment of it into the CRISPR array as a new spacer.
Explanation: Spacers are short segments of DNA captured from invading phages. These 'mugshots' allow the bacteria to recognize and target the same virus if it attacks again.
Explanation: In nature, the crRNA and tracrRNA exist as two separate molecules that form a dual-RNA complex. The synthetic 'sgRNA' used in labs is a man-made fusion of these two.
Explanation: Germline editing affects the DNA in sperm, eggs, or embryos, meaning the changes are passed down to all future generations, raising significant ethical and regulatory concerns.
Explanation: Cas13 targets RNA. Once it binds to its target, it becomes 'activated' and starts cutting any nearby RNA molecules (collateral cleavage), which can be used to release fluorescent signals for diagnostics.
Explanation: CRISPR activation (CRISPRa) utilizes dCas9 to recruit transcriptional machinery to a promoter, inducing the expression of the target gene.
Explanation: While Cas9 creates blunt-end cuts, Cas12a creates staggered cuts with short overhanging 'sticky' ends, which can be more useful for certain types of DNA cloning and assembly.
Explanation: AcrIIA4 mimics the negative charge of DNA to occupy the PAM-interacting domain of Cas9, preventing the enzyme from binding to its genomic target.
Explanation: Cas9 uses two domains to cut DNA: the HNH domain cuts the strand complementary to the guide RNA, and the RuvC domain cuts the non-complementary strand.
Explanation: Once Cas13 binds its specific RNA target, it undergoes a conformational change that activates non-specific RNase activity, cleaving nearby RNA molecules.
Explanation: Multiplexing allows for complex genetic engineering by targeting multiple sites in the genome at once, which is useful for studying polygenic diseases or complex metabolic pathways.
Explanation: CRISPR-Cas9 evolved as an adaptive immune system in bacteria and archaea, allowing them to recognize and cleave foreign genetic material from invading viruses (bacteriophages).
Explanation: The Bridge Helix is an arginine-rich alpha-helix that links the Recognition (REC) lobe and the Nuclease (NUC) lobe, coordinating conformational changes.
Explanation: Type I systems utilize the multi-subunit Cascade complex for targeting and the Cas3 protein, which has both helicase and nuclease activity, for DNA degradation.
Explanation: Charpentier and Doudna were recognized for their 2012 study demonstrating that the CRISPR-Cas9 system could be reprogrammed as a versatile tool for genome editing.
Explanation: MMEJ (also known as Alt-NHEJ) uses short flanking microhomologies to repair breaks, often resulting in predictable deletions rather than random indels.
Explanation: Cytosine base editors (CBEs) deaminate cytosine to uracil, which is then read as thymine by DNA polymerase, effectively converting C-G to T-A base pairs.
Explanation: Epigenetic editing modifies the chemical 'tags' (like methyl groups) on DNA. This can turn genes on or off without altering the underlying genetic code, making the changes potentially reversible.
Explanation: The trans-activating CRISPR RNA (tracrRNA) hybridized with the crRNA to form a dual-RNA structure that loads the Cas9 protein and activates its nuclease activity.
Explanation: Off-target effects occur when the guide RNA binds to a DNA sequence that is a near-match to the intended target, leading to unintended mutations elsewhere in the genome.
Explanation: CRISPR systems are divided into two classes: Class 1 uses multi-subunit effector complexes (Types I, III, IV), while Class 2 uses a single-protein effector (Types II, V, VI).
Explanation: The 8-12 nucleotides at the 3' end of the spacer (closest to the PAM) are called the 'seed sequence'. Mismatches here usually prevent Cas9 from cutting.
Explanation: SpCas9 specifically seeks out the 5'-NGG-3' PAM sequence. If this motif is not present immediately downstream of the target site, Cas9 will not bind or cut the DNA.
Explanation: Homology Directed Repair (HDR) uses a homologous DNA template (provided by the researcher) to precisely repair a double-strand break, allowing for specific sequence changes.
Explanation: GUIDE-seq (Genome-wide Unbiased Identification of DSBs Enabled by sequencing) tags double-strand breaks with dsODNs to map where Cas9 cuts across the genome.
Explanation: The Recognition (REC) lobe is a large, alpha-helical domain that serves as a scaffold to hold the guide RNA and the target DNA heteroduplex in place.
Explanation: Gene drives use CRISPR to copy themselves onto the homologous chromosome, bypassing standard Mendelian inheritance and ensuring the trait spreads rapidly through a population.
Explanation: Base editing uses a modified Cas9 fused to a deaminase enzyme to chemically transform one nitrogenous base into another, offering high precision for point mutations.
Explanation: The PAM is essential for distinguishing the bacteria's own CRISPR locus (which lacks the PAM) from the invading viral DNA, preventing the system from destroying its own genome.
Explanation: The WHO formed an expert committee to create a framework for governing human genome editing to ensure it is used safely, ethically, and transparently across the globe.
Explanation: LNPs deliver mRNA or RNP complexes that degrade quickly, ensuring the Cas9 is only present briefly, which significantly reduces the risk of off-target mutations.
Explanation: NHEJ is the default, error-prone repair mechanism that joins broken DNA ends. It often results in small insertions or deletions (indels) that disrupt the gene's function.
Explanation: Ex vivo (out of the living) involves removing a patient's cells, editing them in a lab, and then returning the modified cells to the patient, as seen in many blood disorder treatments.
Explanation: The Patent Trial and Appeal Board (PTAB) ruled that using CRISPR in eukaryotic cells was a distinct, non-obvious invention from the original work in test tubes.
Explanation: dCas9 can bind to a target DNA sequence but cannot cut it. It is often fused to other proteins to turn genes on or off (CRISPRa/CRISPRi) without changing the DNA sequence.
Explanation: The trans-activating CRISPR RNA (tracrRNA) base-pairs with the crRNA to form a structure that is recognized and bound by the Cas9 protein.
Explanation: Anti-CRISPR proteins are an evolutionary counter-defense developed by viruses to block the bacterial CRISPR-Cas system and allow the virus to replicate successfully.
Explanation: HDR is naturally much less efficient than NHEJ in most human cells, especially in non-dividing tissues like the brain or muscles, making gene correction difficult.
Explanation: ABEs use an engineered deoxyadenosine deaminase to convert adenine to inosine, which the cell's machinery treats as guanine, resulting in an A-to-G transition.
Explanation: The standard SpCas9 and its guide RNA barely fit into an AAV vector. This has led researchers to seek smaller Cas variants, like SaCas9 (from S. aureus), for better delivery.